Holen Sie sich die Stockscreener-App
138.38
0.54%
0.74
Handel nachbörslich:
138.38
Schlusskurs vom Vortag:
$137.64
Offen:
$137.23
24-Stunden-Volumen:
545.10K
Relative Volume:
0.73
Marktkapitalisierung:
$8.39B
Einnahmen:
$4.09B
Nettoeinkommen (Verlust:
$-404.84M
KGV:
-20.51
EPS:
-6.7469
Netto-Cashflow:
$1.24B
1W Leistung:
-0.68%
1M Leistung:
-0.79%
6M Leistung:
+15.27%
1J Leistung:
+25.29%
1-Tages-Spanne:
$136.66
$138.45
1-Wochen-Bereich:
$133.45
$139.73
52-Wochen-Spanne:
$95.49
$148.06
Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile
Firmenname
Jazz Pharmaceuticals Plc
Sektor
Branche
Telefon
353-1-634-7800
Adresse
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
Vergleichen Sie JAZZ mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
JAZZ
Jazz Pharmaceuticals Plc
|
138.38 | 8.35B | 4.09B | -404.84M | 1.24B | -6.7469 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-15 | Eingeleitet | Deutsche Bank | Buy |
| 2025-03-07 | Hochstufung | UBS | Neutral → Buy |
| 2025-02-26 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-02-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-12-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-06-05 | Eingeleitet | Goldman | Buy |
| 2024-01-03 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-11-27 | Herabstufung | UBS | Buy → Neutral |
| 2023-09-29 | Eingeleitet | Raymond James | Mkt Perform |
| 2023-06-12 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2022-12-09 | Hochstufung | Goldman | Neutral → Buy |
| 2022-06-14 | Eingeleitet | UBS | Buy |
| 2022-04-06 | Herabstufung | Goldman | Buy → Neutral |
| 2021-11-19 | Fortgesetzt | Goldman | Buy |
| 2021-10-07 | Fortgesetzt | Jefferies | Buy |
| 2021-10-05 | Eingeleitet | Citigroup | Buy |
| 2021-09-23 | Eingeleitet | Needham | Buy |
| 2021-05-19 | Fortgesetzt | JP Morgan | Overweight |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2021-02-05 | Bestätigt | H.C. Wainwright | Buy |
| 2021-02-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-01-29 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-16 | Eingeleitet | UBS | Buy |
| 2020-11-03 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-09 | Bestätigt | H.C. Wainwright | Buy |
| 2020-09-14 | Herabstufung | Goldman | Neutral → Sell |
| 2020-09-14 | Fortgesetzt | JP Morgan | Overweight |
| 2020-08-06 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-07-28 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-07-23 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-04-06 | Eingeleitet | Jefferies | Buy |
| 2020-03-12 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2020-01-08 | Eingeleitet | Goldman | Neutral |
| 2019-08-21 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2019-06-11 | Eingeleitet | Barclays | Overweight |
| 2019-03-20 | Eingeleitet | SunTrust | Buy |
| 2018-12-14 | Eingeleitet | Wolfe Research | Peer Perform |
| 2018-11-08 | Bestätigt | B. Riley FBR | Buy |
| 2018-08-08 | Bestätigt | Stifel | Buy |
| 2018-07-11 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-03-23 | Bestätigt | H.C. Wainwright | Neutral |
| 2018-03-19 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
Alle ansehen
Jazz Pharmaceuticals Plc Aktie (JAZZ) Neueste Nachrichten
A Fresh Look at Jazz Pharmaceuticals (JAZZ) Valuation Following Landmark Settlement With Avadel - simplywall.st
Live market analysis of Jazz Pharmaceuticals plcCPI Data & Advanced Technical Analysis Signals - newser.com
Earnings To Watch: Jazz Pharmaceuticals (JAZZ) Reports Q3 Results Tomorrow - Yahoo! Finance UK
Technical analysis overview for Jazz Pharmaceuticals plc stockDay Trade & Real-Time Stock Price Movement Reports - newser.com
Can Jazz Pharmaceuticals plc stock hit record highs again2025 Retail Activity & Low Risk Entry Point Tips - newser.com
Will Jazz Pharmaceuticals plc (J7Z) stock outperform benchmarksWeekly Earnings Recap & Long-Term Investment Growth Plans - newser.com
Can Jazz Pharmaceuticals plc stock resist sector downturns2025 Volume Leaders & Weekly Return Optimization Alerts - newser.com
Why Jazz Pharmaceuticals plc stock is trending among retail tradersTrade Entry Summary & Weekly Watchlist of Top Performers - newser.com
How strong is Jazz Pharmaceuticals plc stock revenue growthWeekly Trade Recap & Risk Controlled Swing Alerts - newser.com
Why Jazz Pharmaceuticals plc (J7Z) stock could be next leaderStop Loss & Proven Capital Preservation Tips - newser.com
Will Jazz Pharmaceuticals plc stock see PE expansion2025 Price Action Summary & Real-Time Price Movement Reports - newser.com
How Jazz Pharmaceuticals plc stock trades during market volatilityWeekly Profit Analysis & Low Risk Profit Maximizing Plans - newser.com
Forecasting Jazz Pharmaceuticals plc price range with options dataIndex Update & Free Technical Confirmation Trade Alerts - newser.com
Best data tools to analyze Jazz Pharmaceuticals plc stock2025 Big Picture & AI Powered Trade Plan Recommendations - newser.com
How Jazz Pharmaceuticals plc (J7Z) stock performs in easing cyclesMarket Activity Summary & Entry Point Strategy Guides - newser.com
What Jazz Pharmaceuticals (JAZZ)'s Cross-Licensing Settlement With Avadel Means For Shareholder Value - Yahoo Finance
Assetmark Inc. Purchases 82,275 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Are Jazz Pharmaceuticals Shares Still Attractive After a 25% Climb and New Pipeline Developments? - simplywall.st
Multi factor analysis applied to Jazz Pharmaceuticals plc2025 Market Overview & AI Forecast for Swing Trade Picks - newser.com
Jazz Pharmaceuticals PLC $JAZZ Shares Purchased by Kovack Advisors Inc. - MarketBeat
Statistical indicators supporting Jazz Pharmaceuticals plc’s strengthJuly 2025 Setups & AI Enhanced Trading Signals - newser.com
Impact Partnership Wealth LLC Takes Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
When is the best time to exit Jazz Pharmaceuticals plcJuly 2025 Outlook & Low Risk High Win Rate Picks - newser.com
Jazz Pharmaceuticals PLC (JAZZ) - MSN
How Investors May Respond To Jazz Pharmaceuticals (JAZZ) Settling Global LUMRYZ Patent Dispute with Avadel - simplywall.st
Is Jazz Pharmaceuticals plc (J7Z) stock a momentum leaderTrade Ideas & Long-Term Investment Growth Plans - newser.com
Why Jazz Pharmaceuticals plc stock is seen as undervalued2025 Growth vs Value & AI Powered Market Entry Strategies - newser.com
Jazz Pharmaceuticals plc stock outlook for YEARJuly 2025 Outlook & Fast Entry High Yield Tips - newser.com
Is Jazz Pharmaceuticals plc stock a buy before product launchesJuly 2025 Summary & Daily Technical Forecast Reports - newser.com
Jazz Pharmaceuticals plc (JAZZ) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Jazz Pharmaceuticals (JAZZ) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Finanzdaten der Jazz Pharmaceuticals Plc-Aktie (JAZZ)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):